The Role of PARP Inhibitors in Prostate Cancer

Video

Christopher E. Barbieri, MD, PhD, surgeon, researcher in prostate cancer, Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and New-York Presbyterian, discusses the role of PARP inhibitors in castration-resistant prostate cancer.

Newsletter

Stay up to date on practice-changing data in community practice.

Subscribe Now!
Recent Videos
Younger Adults See Sharp Rise in Pancreas & Colon Cancer, Study Shows
Younger Adults See Sharp Rise in Pancreas & Colon Cancer, Study Shows
The Growing Financial Burden on Patients and Caregivers in Cancer Care
The Growing Financial Burden on Patients and Caregivers in Cancer Care
Caregiver & Housing Hurdles: Equity in HCT & CAR T Treatment
Caregiver & Housing Hurdles: Equity in HCT & CAR T Treatment
HCT & CAR T Access: Unseen Barriers & Inequities in Care
HCT & CAR T Access: Unseen Barriers & Inequities in Care
Understanding Why Darolutamide Stands Out Among ARPIs for mHSPC
Understanding Why Darolutamide Stands Out Among ARPIs for mHSPC
Weiss on How Nanoparticles are Enhancing Radiation Therapy in Lung Cancer
Weiss on How Nanoparticles are Enhancing Radiation Therapy in Lung Cancer
Navigating the Complexities of Immunotherapy in ALL
Navigating the Complexities of Immunotherapy in ALL
First-Line CLL/SLL: Is Chemo-Free the Future?
First-Line CLL/SLL: Is Chemo-Free the Future?
SC Pembrolizumab Noninferior to IV in NSCLC: Phase 3 Trial Results
SC Pembrolizumab Noninferior to IV in NSCLC: Phase 3 Trial Results
Elmariah on the Evolving Role of Fedratinib
Elmariah on the Evolving Role of Fedratinib
Related Content
Expert Panel Addresses 5 Areas of Need in Metastatic Prostate Cancer

Expert Panel Addresses 5 Areas of Need in Metastatic Prostate Cancer

Morgan Bayer
April 23rd 2025
Article

Experts developed consensus recommendations through the modified Delphi process for metastatic prostate cancer management during the 2024 US Prostate Cancer Conference.

Read More

Transforming Prostate Cancer Care Through Personalized Medicine

Transforming Prostate Cancer Care Through Personalized Medicine

Jordyn Sava;Adam Weiner, MD
July 1st 2024
Podcast

Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.

Listen

AUA 2025: A Sneak Peek for Community Oncologists/Urologists

AUA 2025: A Sneak Peek for Community Oncologists/Urologists

Jordyn Sava
April 22nd 2025
Article

At AUA 2025, experts will present on novel bladder cancer therapies, advanced renal cell carcinoma comparisons, frailty in prostate cancer, and more.

Read More

Dizman’s Global Pursuit to Cancer Research and Understanding

Dizman’s Global Pursuit to Cancer Research and Understanding

Jordyn Sava;Nazli Dizman, MD
April 1st 2024
Podcast

In this episode of Emerging Experts, Nazli Dizman, MD, shares the intricacies of her journey towards becoming an oncologist in the United States.

Listen

Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC

Leighl Covers PALOMA-3 Trial of SC Amivantamab in NSCLC

Jordyn Sava
April 18th 2025
Article

Natasha Leighl, MD, MMSc, BSc, discussed key findings from the PALOMA-3 trial for a community oncologist audience.

Read More

New Phase in Prostate Cancer Fight: Cu-SAR-bisPSMA Trial Begins

New Phase in Prostate Cancer Fight: Cu-SAR-bisPSMA Trial Begins

Sabrina Serani
April 16th 2025
Article

The first patient in a phase 2 clinical trial evaluating 67Cu-SAR-bisPSMA for patients with metastatic castration-resistant prostate cancer has been dosed.

Read More